Status:
RECRUITING
Sepsis in the ICU-II
Lead Sponsor:
Linkoeping University
Collaborating Sponsors:
Centre Hospitalier Universitaire Dijon
Ryhov Hospital, Jönköping
Conditions:
Septic Shock
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
Sepsis-induced cardiac dysfunction (SIMD) is a well-known phenomenon yet its diagnosis remains elusive with no accepted definition, or defining pathophysiological mechanism associated with this diseas...
Detailed Description
UPDATE 26 Feb 2022: A pilot project was completedafter recruitment of 50 patients confirming the feasibility of data collection, study logistics, biomarker assay set-up and frequency of outcomes. Can...
Eligibility Criteria
Inclusion
- Adult patients admitted to ICU and fulfilling the Sepsis-III criteria for septic shock
Exclusion
- No informed consent
- Acute coronary syndromes
Key Trial Info
Start Date :
September 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT04695119
Start Date
September 17 2018
End Date
December 31 2025
Last Update
November 13 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Dijon-Bourgogne
Dijon, Dijon, France, 21000
2
CHU Georges Pompidou
Paris, Paris, France, 75015
3
Ryhov Sjukhus Jönköping
Jönköping, Jönköping County, Sweden, 55305
4
Dept of Anaesthesia and Intensive Care
Linköping, Sweden, 58185